Nardev S. Khurmi

Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes

Hertzel C. Gerstein, Naveed Sattar, Julio Rosenstock et al. · New England Journal of Medicine · 2021 · 719 citations · Full text

Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study

Christopher P. Cannon, Robert A. Harrington, Stefan James et al. · The Lancet · 2010 · 658 citations

Thrombosis, Randomised Double-blind Study, Cardiovascular Disease +13

Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes

Robert F. Storey, Richard C. Becker, Robert A. Harrington et al. · European Heart Journal · 2011 · 200 citations · Full text

Dyspnoea Ae, Pharmacotherapy, Coronary Artery Disease +18

Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and a History of Stroke or Transient Ischemic Attack

Stefan James, Robert F. Storey, Nardev S. Khurmi et al. · Circulation · 2012 · 131 citations · Full text

Baseline Characteristics of Participants in the JUPITER Trial, A Randomized Placebo-Controlled Primary Prevention Trial of Statin Therapy Among Individuals With Low Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein

Paul M. Ridker, Francisco Antônio Helfenstein Fonseca, Jacques Genest et al. · The American Journal of Cardiology · 2007 · 125 citations · Full text

Jupiter Trial, Preventive Medicine, Health Policy +8